Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-28982
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
A cross-site scripting (XSS) vulnerability in Liferay Portal v7.3.3 through v7.4.2 and Liferay DXP v7.3 before service pack 3 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the name of a tag.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Liferay Portal和Liferay DXP 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Liferay Portal和Liferay DXP都是美国Liferay公司的产品。Liferay Portal是一套基于J2EE的门户解决方案。该方案使用了EJB以及JMS等技术,并可作为Web发布和共享工作区、企业协作平台、社交网络等。Liferay DXP是一套数字化体验协作平台。 Liferay Portal v7.3.3版本至v7.4.2版本、Liferay DXP v7.3之前版本存在安全漏洞。攻击者利用该漏洞可借助注入标签名称的特制有效载荷执行任意web脚本或HTML。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2022-28982
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2022-28982
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2022-28982

No comments yet


Leave a comment